Ratings by H.C. Wainwright (Andres Y. Maldonado)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | Monopar Therapeutics | MNPR | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2026 | Monopar Therapeutics | MNPR | Maintain | Buy (Buy) |
|
Details | ||
| 4/28/2026 | Erasca Inc | ERAS | Maintain | Buy (Buy) |
|
Details | ||
| 3/13/2026 | Erasca Inc | ERAS | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2026 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
23.41 (21.19) |
-9.48% | Details | |
| 1/26/2026 | Erasca Inc | ERAS | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Erasca Inc | ERAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | Merus N.V. | MRUS | Downgrade | Neutral (Buy) |
68.89 (90.00) |
30.64% | Details | |
| 9/29/2025 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2025 | Monopar Therapeutics | MNPR | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (Buy) |
|
Details | ||
| 5/7/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (Buy) |
|
Details | ||
| 11/8/2024 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Corbus Pharmaceuticals | CRBP | Maintain | Buy (Buy) |
|
Details | ||
| 8/13/2024 | Erasca Inc | ERAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Corbus Pharmaceuticals | CRBP | New Coverage | Buy (N/A) |
58.00 (9.38) |
-83.83% | Details | |
| 5/29/2024 | Ikena Oconology | IKNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | Erasca Inc | ERAS | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2023 | Erasca Inc | ERAS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Ikena Oconology | IKNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2023 | Erasca Inc | ERAS | New Coverage | Buy (N/A) |
2.49 (18.32) |
635.74% | Details |
